Sort
23,748 grants matching “melanoma”
Coordinating tumor differentiation and immune suppression with the metabolic state and treatment outcome
$382,051Hans Ragnar Widlund · Brigham And Women'S Hospital · R01 · FY2020 · CA
(PQD1) Clonal heterogeneity and targeted therapy resistance in melanoma
$382,030Aleksandar None Sekulic · Mayo Clinic Arizona · R01 · FY2014 · CA
Training Program in Cancer Immunobiology
$382,016Bradley W McIntyre · University Of Tx Md Anderson Can Ctr · T32 · FY2007 · CA
Cellular Mechanisms of Therapy Resistance in Melanoma
$382,016Meenhard Herlyn · Wistar Institute · P01 · FY2011 · CA
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
$382,013Fernando Macian · Albert Einstein College Of Medicine · R01 · FY2020 · CA
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
$382,013Fernando Macian · Albert Einstein College Of Medicine · R01 · FY2021 · CA
Therapeutic Mechanism of CD47 Blockade in Suppressing Melanoma Metastasis
$382,013Alexander D Boiko · Cedars-Sinai Medical Center · R01 · FY2021 · CA
Therapeutic Mechanism of CD47 Blockade in Suppressing Melanoma Metastasis
$382,012Alexander D Boiko · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Nucleic acid modulators and theranostics for ADAR
$381,938Guizhi Zhu · University Of Michigan At Ann Arbor · R35 · FY2023 · GM
Nucleic acid modulators and theranostics for ADAR
$381,938Guizhi Zhu · University Of Michigan At Ann Arbor · R35 · FY2024 · GM
Nucleic acid modulators and theranostics for ADAR
$381,938Guizhi Zhu · University Of Michigan At Ann Arbor · R35 · FY2025 · GM
Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment
$381,907Jenny J Yang · Georgia State University · R33 · FY2020 · CA
Project 1: Siglec15 as a new target for lung cancer immunotherapy
$381,856Lieping Chen · Yale University · P50 · FY2020 · CA
A NOVEL DRUGGABLE GENETIC VULNERABILITY PATHWAY IN MELANOMA
$381,822Narendra Wajapeyee · Yale University · R01 · FY2016 · CA
The role of RB in the retina & other tissues
$381,770James W Harbour · Washington University · R01 · FY2006 · EY
PDK1 as a Novel Target in Melanoma
$381,728Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · CA
Optimal Pairing of Chemotherapy with Immunotherapy for Pancreatic Cancer
$381,692Peter A Cohen · Mayo Clinic Rochester · P50 · FY2015 · CA
Adhesive Signaling by Platelet Integrins
$381,687Sanford J Shattil · University Of California, San Diego · R01 · FY2015 · HL
Novel Nanotechnologies and Molecular Imaging Approaches for Cancer Immunotherapy
$381,654Caius Gabriel Radu · California Institute Of Technology · U54 · FY2010 · CA
Project 3: Localized microneedle-directed combination immunotherapy for cSCC
$381,600Louis D Falo · University Of Pittsburgh At Pittsburgh · P50 · FY2024 · CA
Project 1: Evaluating the synergy of LAG3 and PD-1 in melanoma patients
$381,600Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P50 · FY2024 · CA
Project 4: Neoadjuvant Clinical Trial with Pembrolizumab for Locally Advanaced Squamous Cell Carcinoma (SCC)
$381,600Hassane M Zarour · University Of Pittsburgh At Pittsburgh · P50 · FY2024 · CA
Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment
$381,589Jenny J Yang · Georgia State University · R33 · FY2021 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$381,557Tufts Medical Center · U10 · FY2002 · CA
Tailored Intervention for Melanoma Patients' Families
$381,555Sharon L Manne · Fox Chase Cancer Center · R01 · FY2007 · CA